KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Halozyme Therapeutics (HALO) Other Non-Current Liabilities (2016 - 2025)

Halozyme Therapeutics (HALO) has disclosed Other Non-Current Liabilities for 13 consecutive years, with $113.9 million as the latest value for Q4 2025.

  • Quarterly Other Non-Current Liabilities rose 107.94% to $113.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $113.9 million through Dec 2025, up 107.94% year-over-year, with the annual reading at $113.9 million for FY2025, 107.94% up from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $113.9 million at Halozyme Therapeutics, up from $71.8 million in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $130.0 million in Q2 2022, with the low at $171000.0 in Q1 2022.
  • Average Other Non-Current Liabilities over 5 years is $43.4 million, with a median of $30.9 million recorded in 2024.
  • The sharpest move saw Other Non-Current Liabilities crashed 93.91% in 2022, then soared 17194.15% in 2023.
  • Over 5 years, Other Non-Current Liabilities stood at $544000.0 in 2021, then skyrocketed by 2744.12% to $15.5 million in 2022, then skyrocketed by 143.8% to $37.7 million in 2023, then surged by 45.17% to $54.8 million in 2024, then soared by 107.94% to $113.9 million in 2025.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods came in at $113.9 million, $71.8 million, and $77.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.